We are live on
!
Find out more
GWM
Graybill Wealth Management Portfolio holdings
AUM
$328M
1-Year Est. Return
21.42%
This Fund
S&P 500
This Quarter
Est. Return
-1.26%
1 Year Est. Return
+21.42%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$205M
AUM Growth
-$15.5M
(-7%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
37.82%
Holding
52
New
2
Increased
34
Reduced
13
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.03M |
| 2 |
CarMax
KMX
|
+$1.06M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$734K |
| 4 |
Visa
V
|
+$728K |
| 5 |
Southern Company
SO
|
+$484K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$4.24M |
| 2 |
Pfizer
PFE
|
+$3.84M |
| 3 |
Meta Platforms (Facebook)
META
|
+$3.6M |
| 4 |
Cheniere Energy
LNG
|
+$1.59M |
| 5 |
Apple
AAPL
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.41% |
| 2 | Financials | 14.17% |
| 3 | Healthcare | 12.32% |
| 4 | Communication Services | 10.45% |
| 5 | Industrials | 10.07% |
Similar funds
MLICM
SM
BOSSRA
KSCM
BAM
YAL
BPWM
AFS
Graybill Wealth Management's Q1 2022 Portfolio in Review
As of Q1 2022, Graybill Wealth Management held 52 positions worth $205M, down 7% from $221M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Graybill Wealth Management withdrew a net $10.2M in Q1 2022, closing 3 positions and reducing 13 holdings. Its most notable exit was Pfizer, an estimated $3.84M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Graybill Wealth Management opened a new position in Microsoft worth $4.13M.
- Graybill Wealth Management's largest Q1 2022 buy was Microsoft: 13,403 shares worth $4.13M.
- Graybill Wealth Management added most to CarMax in Q1 2022, an estimated $1.06M increase.
- Graybill Wealth Management's biggest Q1 2022 reduction was Unilever, cutting an estimated $4.24M.
- Graybill Wealth Management fully exited Pfizer in Q1 2022, selling an estimated $3.84M.
- Graybill Wealth Management's ten largest holdings make up 38% of its $205M portfolio in Q1 2022.
- Graybill Wealth Management opened 2 new positions and closed 3 in Q1 2022.
- Graybill Wealth Management's portfolio value fell 7% quarter-over-quarter to $205M.
Based on Graybill Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.